Allianz Asset Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.19M Buy
301,473
+1,820
+0.6% +$41.7K 0.01% 1282
2026
Q1
$6.6M Buy
299,653
+60,256
+25% +$1.05M 0.01% 1040
2025
Q4
$2.82M Sell
239,397
-324,612
-58% -$4.17M ﹤0.01% 1412
2025
Q3
$8.93M Buy
564,009
+95,185
+20% +$1.38M 0.01% 889
2025
Q2
$5.37M Sell
468,824
-200,779
-30% -$2.26M 0.01% 1079
2025
Q1
$9.06M Buy
669,603
+227,566
+51% +$3.78M 0.01% 834
2024
Q4
$7.47M Buy
442,037
+185,379
+72% +$3.61M 0.01% 866
2024
Q3
$5.22M Buy
256,658
+127,015
+98% +$2.6M 0.01% 1027
2024
Q2
$2.93M Buy
+129,643
New +$3.39M ﹤0.01% 1172
2023
Q4
Sell
-44,147
Closed -$1.24M 2144
2023
Q3
$1.24M Buy
44,147
+32,149
+268% +$1.1M ﹤0.01% 1631
2023
Q2
$443K Buy
11,998
+1,823
+18% +$55.6K ﹤0.01% 1765
2023
Q1
$305K Sell
10,175
-711
-7% -$23.4K ﹤0.01% 1986
2022
Q4
$333K Buy
+10,886
New +$327K ﹤0.01% 1799
2022
Q3
Sell
-532,069
Closed -$17M 1920
2022
Q2
$17M Sell
532,069
-959,664
-64% -$35.3M 0.02% 725
2022
Q1
$47M Sell
1,491,733
-486,129
-25% -$15.2M 0.04% 476
2021
Q4
$66.4M Buy
1,977,862
+321,627
+19% +$10M 0.05% 409
2021
Q3
$48.1M Sell
1,656,235
-2,588,981
-61% -$83.8M 0.04% 443
2021
Q2
$148M Buy
4,245,216
+918,918
+28% +$30.4M 0.12% 173
2021
Q1
$92.8M Sell
3,326,298
-122,001
-4% -$3.25M 0.09% 230
2020
Q4
$85.5M Sell
3,448,299
-186,402
-5% -$4.44M 0.08% 238
2020
Q3
$76M Buy
3,634,701
+820,989
+29% +$15.8M 0.09% 239
2020
Q2
$43.2M Buy
2,813,712
+703,968
+33% +$8.9M 0.05% 367
2020
Q1
$18.7M Sell
2,109,744
-1,463
-0.1% -$21.1K 0.03% 588
2019
Q4
$38.2M Sell
2,111,207
-324
-0% -$5.38K 0.03% 515
2019
Q3
$31.5M Sell
2,111,531
-11,986
-0.6% -$195K 0.03% 598
2019
Q2
$51M Sell
2,123,517
-130
-0% -$3.83K 0.05% 415
2019
Q1
$78.9M Sell
2,123,647
-86,942
-4% -$3.16M 0.08% 278
2018
Q4
$62.4M Sell
2,210,589
-2,421
-0.1% -$76.6K 0.07% 306
2018
Q3
$87.3M Sell
2,213,010
-238,534
-10% -$10.4M 0.08% 271
2018
Q2
$109M Sell
2,451,544
-17,551
-0.7% -$873K 0.11% 212
2018
Q1
$120M Buy
2,469,095
+228,558
+10% +$11.4M 0.11% 200
2017
Q4
$112M Sell
2,240,537
-428,034
-16% -$22.4M 0.09% 275
2017
Q3
$135M Sell
2,668,571
-340,273
-11% -$16.1M 0.12% 201
2017
Q2
$114M Buy
3,008,844
+70,819
+2% +$2.79M 0.11% 214
2017
Q1
$113M Buy
2,938,025
+2,133,561
+265% +$64.2M 0.11% 199
2016
Q4
$17.8M Buy
804,464
+656,187
+443% +$13.5M 0.02% 1075
2016
Q3
$2.35M Buy
148,277
+67,090
+83% +$766K ﹤0.01% 1936
2016
Q2
$669K Buy
81,187
+2,292
+3% +$20.4K ﹤0.01% 2248
2016
Q1
$552K Sell
78,895
-162,028
-67% -$814K ﹤0.01% 2239
2015
Q4
$1.28M Buy
240,923
+88,879
+58% +$568K ﹤0.01% 1884
2015
Q3
$983K Buy
+152,044
New +$1.59M ﹤0.01% 1844

Other funds holding CC

Allianz Asset Management's CC Position: Q2 2026 in Review

Allianz Asset Management increased its Chemours (CC) stake by 0.61% in Q2 2026, buying an estimated $41.7K and bringing the position to 301,473 shares worth $6.19M. The position accounts for 0.01% of the portfolio, ranked #1282.

Allianz Asset Management first reported a position in CC in Q3 2015 and has held it in 41 quarters since. The position peaked at $148M in Q2 2021. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Allianz Asset Management held 301,473 shares of Chemours worth $6.19M as of Q2 2026.
  • Allianz Asset Management bought 1,820 Chemours shares in Q2 2026, an estimated $41.7K.
  • Chemours made up 0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1282 holding.
  • Allianz Asset Management first reported a position in Chemours in Q3 2015 and has held it in 41 quarters since.
  • Allianz Asset Management's Chemours position peaked at $148M in Q2 2021.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.